David Michael Johnson Insider Profile
18 Followers
David Michael Johnson, Director at Zentalis Pharmaceuticals, holds 307.52K shares in Zentalis Pharmaceuticals (Ticker: ZNTL), holds 483.84K shares in Aura Biosciences Inc (Ticker: AURA).
David Michael Johnson's Trading History
You May Also Like
David Michael Johnson insider profile FAQ
What is the percentage of profitable transactions made by David Michael Johnson?
The percentage of profitable transactions made by David Michael Johnson is 25%.
What is the average return per transaction made by David Michael Johnson?
The average return per transaction made by David Michael Johnson is -5.10%.
What stocks does David Michael Johnson hold?
David Michael Johnson holds: ZNTL, AURA stocks.
What was David Michael Johnson's most profitable transaction?
David Michael Johnson’s most profitable transaction was an Informative Buy of AURA stock on November 9, 2023. The return on the trade was 54.90%.
What is David Michael Johnson's role in Zentalis Pharmaceuticals?
David Michael Johnson's role in Zentalis Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
